May 09, 2023 / 12:00PM GMT
Operator
Good morning, and welcome to Mersana Therapeutics First Quarter 2023 Conference Call and Webcast. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please proceed.
Jason Fredette - Mersana Therapeutics, Inc. - SVP of IR & Corporate Communications
Good morning, everyone. Before we begin, please note that this call will contain forward-looking statements within the meaning of Federal Securities Laws. These statements include, but are not limited to, those related to the therapeutic potential of our product candidates and the potential of our platforms, business strategy, clinical trial design, execution and data releases regulatory plans and objectives, commercial opportunities, collaborations and potential associated payments, operating expenses and cash runway.
Each of these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially
Q1 2023 Mersana Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot